MOv-18 IgE

MOv-18免疫球蛋白E

Report date: 2026/05/20 20:02:01

Base Information

Drug NameMOv-18 IgE
Drug Alias NameMOv18IgEMOv-18 IgEMOv18MOv-18
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionFolate receptor alpha antagonists
TargetsFolate receptor alpha
Therapy Area/IndicationsEndometrial NeoplasmsOvarian NeoplasmsTriple Negative Breast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKing'S College LondonCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesEpsilogen LtdCancer Research UK
Inactive CompaniesN/A
Active IndicationsEndometrial NeoplasmsOvarian NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A